Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Enhertu Bags Breakthrough Therapy Tag for HER2 Low or Ultralow Breast Cancer
August 20, 2024
- Enhertu Grabs Conditional Nod for Gastric Cancer in China: Daiichi Sankyo
August 20, 2024
- Cheplapharm Snags 2 More Brands from Clinigen in Japan
August 20, 2024
- Otsuka Rolls Out Therapeutic App for Depression in US
August 19, 2024
- Fabhalta, Omjjara, Avigan Now Available in Japan
August 19, 2024
- Takeda Gets Japan Approval for Low-Dose Form of Ninlaro
August 19, 2024
- Insud/ASKA’s Birth Control Pill Approved in South Korea
August 19, 2024
- Breyanzi Broadens Label for Follicular Lymphoma in Japan: BMS
August 19, 2024
- Chugai Files DMD Gene Therapy Elevidys in Japan
August 19, 2024
- Rinvoq Filed for Giant Cell Arteritis in Japan: AbbVie
August 19, 2024
- Eisai’s Leqembi Now Approved in UAE
August 19, 2024
- Business Revamp “Just Getting Started”: Sumitomo Pharma CEO
August 19, 2024
- Tremfya Filed for Crohn’s Disease in Japan: J&J
August 13, 2024
- MSD Seeks Japan Nod for 21-Valent Pneumococcal Jab for Adults
August 13, 2024
- Opdivo-Yervoy Combo Filed for HCC in Japan
August 13, 2024
- Takeda Seeks CIDP Nod for Immunoglobulin Hyqvia in Japan
August 9, 2024
- Japan Patented Drug Market Breaks 7 Trillion Yen in FY2023: IQVIA
August 9, 2024
- Hizentra Now Available in Prefilled Syringe Form in Japan: CSL
August 9, 2024
- Nobelpharma to Launch Hypozincemia Drug Zintus on August 20
August 9, 2024
- Pfizer Earns Japan Nod for JN.1-Adapted COVID Vaccine
August 9, 2024
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…